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Striae and Pelvic Relaxation: Two Disorders of
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Sharon A. Salter1,2, Ritu S. Batra1,3, Thomas E. Rohrer3,4, Neeraj Kohli5 and Alexa B. Kimball1,2
Pelvic relaxation, a weakening of pelvic support structures, is an under-reported condition that affects a
multitude of women. In the United States alone, more than 338,000 procedures for prolapse are performed
annually. Decreased collagen content has been noted in the tissues of women affected by this condition.
Interestingly, biopsy specimens of women with striae also show a diminution of collagen. Using self-reported
anonymous data, we compared the prevalence of striae in women with and without pelvic relaxation to see if an
association between these two disorders of connective tissue existed. More than half the women with prolapse
(54.7%) (n¼ 41) reported striae, whereas only 25.0% of women in the non-prolapse group (n¼ 8) reported striae
(Po0.01). Multivariate logistic regression analysis confirmed striae as a significant risk factor for the
development of clinical prolapse (odds ratio 3.12, Po0.05). There appears to be a strong association between
the presence of striae and the development of pelvic relaxation, which is unrelated to conventionally cited risk
factors, such as age, weight, number of pregnancies, or postmenopausal status.
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INTRODUCTION
Pelvic relaxation in women is a condition in which pelvic
support structures weaken and allow pelvic organs, such as
the uterus, bladder, or rectum, to prolapse, and in some cases
protrude partially or completely through the vaginal introitus.
Symptoms associated with this condition include pelvic
pressure, pain, seeing or feeling a vaginal bulge, and
incontinence (urinary and/or rectal) (Fornell et al., 2004;
Smith and Appell, 2005). Currently, aging, childbirth, chronic
straining or coughing, weak levator ani musculature, and
neurological injury are considered potential risk factors
(Michael et al., 2003), but there are no reliable methods for
predicting who will develop pelvic relaxation. A non-
invasive, cost-effective screening method for the early
identification of women at high risk for the development of
pelvic relaxation and its resultant morbidities would enable
the implementation of preventive strategies, such as pelvic
floor muscle exercises, when they would be most beneficial.
As a decrease in collagen content has been noted in both
striae (Watson et al., 1998) and pelvic relaxation (Goh, 2003;
Michael et al., 2003), we designed a study that would
compare the prevalence of striae in women with and without
pelvic relaxation to see if an association existed between
these two disorders of connective tissue that might ultimately
be used to identify high risk individuals.
RESULTS
The study was performed using a total of 116 surveys
collected from urogynecology patients (n¼71) and skin
cancer patients (n¼45). The surveys were completed in the
waiting rooms or exam rooms, before each patient’s
appointment. Among all respondents, the average age was
59.7 years (range 25–90 years), average weight was 151.7 lbs
(range 98–279 lbs), and average number of pregnancies was
2.2 (range 0–8). One hundred eight (93.1%) respondents
provided complete information regarding prolapse symp-
toms. A board certified obstetrician/gynecologist (S.A.S.)
reviewed each questionnaire to assess self-reported symp-
toms associated with a diagnosis of clinical prolapse (Fornell
et al., 2004; Smith and Appell, 2005). Self-reported symp-
toms included any one or more of the following: pelvic
pressure, urinary incontinence, protrusion of pelvic organs
through the vagina, or a ‘‘falling down’’ or ‘‘dropped’’
sensation. The frequency of each symptom among subjects
with clinical prolapse was 25.0, 50.9, 24.1, and 26.7%,
respectively. A total of 70.4% (n¼ 76) of respondents were
classified in the clinical prolapse category on the basis of
either a previous diagnosis or self-reported symptoms. The
majority of the patients with clinical prolapse came from the
urogynecology group with a prevalence more than double
that found in the Mohs group (81.7 vs 40%, n¼ 58 vs 18).
Unexpectedly, 87% of women in the non-prolapse group
compared to 63.0% of women in the prolapse group were
postmenopausal (Po0.02). When the group with prolapse
and the group without prolapse were compared by age,
See related commentary on page 1688
& 2006 The Society for Investigative Dermatology www.jidonline.org 1745
ORIGINAL ARTICLE
Received 23 August 2005; revised 16 December 2005; accepted 23 January
2006; published online 23 March 2006
1Department of Dermatology, Brigham and Women’s Hospital, Boston,
Massachusetts, USA; 2Department of Dermatology, Massachusetts General
Hospital, Boston, Massachusetts, USA; 3SkinCare Physicians, Chestnut Hill,
Massachusetts, USA; 4Boston University School of Medicine, Boston,
Massachusetts, USA and 5Department of Urogynecology, Brigham and
Women’s Hospital, Boston, Massachusetts, USA
Correspondence: Dr Alexa B. Kimball, Department of Dermatology, Brigham
and Women’s Hospital, 221 Longwood Avenue, Boston, Massachusetts
02115, USA. Email: akimball@partners.org
weight, skin type, presence of hemorrhoids, presence of
varicose veins, easy bruising, hypertension, preterm labor,
and number of pregnancies, no statistically significant
differences were noted (see Table 1).
The overall prevalence of striae was 46.5% (n¼ 53), but
more than half the women with prolapse (54.7%) (n¼41)
reported striae, whereas only 25.0% of women in the non-
prolapse group (n¼8) reported striae (Po0.01). When
comparing subjects with and without striae, the presence of
varicose veins and weight were the only variables in which a
significant difference was detected (see Table 2). Varicose
veins affected 26.4% of women with striae (n¼14) and only
11.5% of the women without striae (n¼7, Po0.05); the
number of pregnancies, oral steroid use, easy bruising,
hypertension, preterm labor, and presence of hemorrhoids
were not significantly different between the two groups. The
mean weight for subjects with striae was 161 lbs, but 143 lbs
for those without striae (Po0.01). When controlling for
weight between the prolapse and non-prolapse groups,
however, the odds ratio for striae as a predictor of clinical
prolapse was 3.39 (Po0.02), demonstrating that the presence
of striae, independent of weight, is a risk factor for the
development of prolapse. In addition, a multivariate analysis
controlling for age, weight, postmenopausal status, varicose
veins, hemorrhoids, preterm labor, number of pregnancies,
and use of oral steroids identified striae as the only significant
predictor of clinical prolapse (odds ratio 3.12, Po0.05,
Table 3).
DISCUSSION
There is no consensus as to how many women are affected by
pelvic relaxation. The literature reports a prevalence rate of
prolapse of 7–70%, depending on the population being
studied (Samuelsson et al., 1999; Swift, 2000; Hendrix et al.,
2002; Piya-Anant et al., 2003; Chuenchompoonut et al.,
2005; Tegerstedt et al., 2005), but many women with
prolapse are not formally diagnosed and, therefore, the
condition is probably far more prevalent than currently
estimated. Many women are symptomatic but are older and
do not routinely see a gynecologist, may be embarrassed and
do not seek care, or are uninformed and do not know that
there are treatments available, all of which likely leads to
under-reporting of this condition. At present, there are no
successful methods for predicting who will develop prolapse.
Early identification of women at risk for the development
of pelvic relaxation and its resultant morbidities may be of
great benefit as several modifiable risk factors (obesity,
smoking, caffeine) have been identified (Bradley and
Nygaard, 2005). There is also evidence that pelvic floor
muscle exercises can retard the progression of already
established severe prolapse (Piya-Anant et al., 2003), and
early treatment may help reduce resultant morbidities such as
cervical ulceration or chronic vulvar irritation. Women who
present with symptoms of pelvic organ prolapse, including
visualization of a bulge from the vagina (Bradley and
Nygaard, 2005), pelvic pressure, urinary incontinence, and
fecal incontinence (Fornell et al., 2004; Smith and Appell,
2005) show greater degrees of pelvic relaxation than women
who present without symptoms (Digesu et al., 2005).
Therefore, it is important to identify those women with
asymptomatic prolapse to prevent the progression of the
condition. A non-invasive cost-effective screening method
that would easily identify at risk women would guide
physicians in counseling patients as to lifestyle changes as
Table 1. Characteristics of women with prolapse
compared to women without prolapse
Variable
Prolapse
(n=76)
Non-prolapse
(n=32) P-value
Mean age 59 64.4 P=0.09
Weight (lbs) 155 148 P=0.31
% Striae 54.7% 25.0% Po0.05
% Postmenopausal 63.5% 86.7% Po0.02
% Varicose veins 22.4% 12.5% P=0.24
% Hemorrhoids 18.4% 21.9% P=0.68
% Preterm labor 2.6% 3.1% P=0.89
Pregnancies (mean) 2.4% 2.0% P=0.29
Table 2. Characteristics of women with striae
compared to women without striae
Variable Striae (n=53) Non-striae (n=61) P-value
Mean age 57.2 61.8 P=0.12
Weight (lbs) 161 144 Po0.01
% Postmenopausal 64.2% 70.2% P=0.51
% Varicose veins 26.4% 11.5% Po0.05
% Hemorrhoids 22.6% 14.8% P=0.28
% Preterm labor 3.8% 1.6% P=0.48
Pregnancies (mean) 2.4 2.0 P=0.14
Table 3. Multivariate analysis of risk factors for pelvic
prolapse
Clinical prolapse
Odds
ratio 95% confidence interval P-value
Age 1.01 0.96 1.06 0.83
Weight 1.01 0.99 1.02 0.51
Stretch marks 3.12 1.04 9.42 0.04
Postmenopausal 0.19 0.03 1.06 0.06
Varicose veins 2.63 0.68 10.17 0.16
Hemorrhoids 0.59 0.17 2.06 0.41
Preterm labor 0.82 0.04 14.99 0.89
Number of pregnancies 1.11 0.83 1.49 0.47
Oral steroids 0.18 0.01 2.46 0.20
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well as allow them to implement treatment strategies early
when they would be most beneficial. Although some of these
symptoms are associated with modifiable lifestyle factors,
such as obesity, smoking, and caffeine intake (Bradley and
Nygaard, 2005), this study suggests there may also be
inherited factors, such as the tendency to develop striae
gravidarum.
Similar to pelvic relaxation, striae distensae (stretch marks)
is a condition with an unknown etiology. There is a lack of
information in the medical literature about striae, but several
potential risk factors including infant birth weight, body mass
index, weight gain in pregnancy, and age (Davey, 1972) have
been proposed. In our study, there was a significant
difference in the average current weights of patients with
striae when compared to those of patients without striae;
however, when controlling for weight between the prolapse
and non-prolapse groups, the odds ratio for striae as a
predictor of clinical prolapse validated that the association
between striae and prolapse is independent of weight.
Controlling for current age, weight, postmenopausal status,
varicose veins, hemorrhoids, preterm labor, number of
pregnancies, and use of oral steroids, striae remained a
significant independent risk factor for the development of
clinical prolapse (Table 3). A recent retrospective study found
that genetic factors, such as personal history, family history,
and race, were the most significant predictors for the
development of striae (Chang et al., 2004). Similarly, our
findings of a higher incidence of striae in women with pelvic
organ prolapse by a 2:1 ratio could potentially be explained
by a common genetically predetermined defect in connective
tissue, in both of these conditions. It also suggests that striae
may indeed have predictive value.
Although this study noted a strong association between
striae and prolapse, there were several potentially confound-
ing variables that were not addressed, including route of
delivery, incidence and degree of laceration at the time of
delivery, duration of pushing at delivery, and the timing or
duration of hormone replacement therapy. In addition, the
diagnosis of clinical prolapse was made based upon self-
reported symptoms, not an actual exam, allowing for the
possibility of misclassification of the subjects. An extension of
this study that controls for the above variables and that uses
pelvic examinations to document the presence or absence of
prolapse would eliminate many of these limitations.
Conclusion
The prevalence of striae in women with pelvic organ prolapse
is more than double of that in women without prolapse. This
strong association between the two conditions suggests that
striae may be considered a risk factor for the development of
pelvic relaxation. Future prospective studies will help clarify
the role of striae as a screening tool for identifying women at
risk for the development of pelvic relaxation.
MATERIALS AND METHODS
The source population consisted of two groups of subjects, those
being seen in an outpatient urogynecology clinic and those being
seen in an outpatient dermatology clinic, from February 2005 to June
2005. The urogynecology patients were chosen owing to the
expected high incidence of prolapse, whereas the dermatology
patients, who were undergoing Mohs micrographic surgery for non-
melanoma skin cancer, were chosen because they were likely to
have similar demographic features, such as age, skin type, and body
mass index, but were not expected to have a higher incidence of
prolapse than in the general population for this age group. Patients
who were interested in participating in the study were instructed to
request a survey, complete the survey anonymously, and either
deposit it in a drop box in the waiting room or hand it to a member of
the office staff. The urogynecology patients requested 83 surveys but
only completed 71 surveys, for a response rate of 85.5%. The
dermatology patients requested 46 surveys and completed 46
surveys, for a response rate of 100%. The surveys included
demographic questions as well as questions about stretch marks,
prolapse, ethnicity, skin type, medical history, and medication
history.
A determination of clinical prolapse was based upon either an
official diagnosis of prolapse as determined by physical exam, or
self-reported symptoms of pelvic pressure, urinary incontinence, or
pelvic organ (uterus/bladder/rectum) protrusion through the vaginal
introitus. Although not diagnostic of pelvic relaxation, there is
evidence that these symptoms are associated with vaginal support
defects (Stenchever and Fenner, 2001; Fornell et al., 2004; Handa
et al., 2004; Bradley and Nygaard, 2005; Smith and Appell, 2005).
Respondents with clinical prolapse were compared to respondents
without clinical prolapse in the categories of age, striae, skin type,
postmenopausal status, hypertension, hemorrhoids, varicose veins,
easy bruising, preterm labor, and number of pregnancies. Surveys
that lacked data for any specific characteristic were not included in
the statistical analysis of that category.
A sample size of 114 subjects was derived by assuming an alpha
of 0.05%, a power of 0.90, an incidence of striae in patients with
pelvic organ prolapse of 80% and an incidence of striae in patients
without pelvic organ prolapse of 50%. These figures were
determined by a previous retrospective study showing the incidence
of striae gravidarum in the general population to be approximately
55% (Chang et al., 2004). Statistical analysis of categorical variables
was implemented using Pearson’s w2 test, whereas continuous
variables were analyzed using the Student’s t-test. Multivariate
logistic regression analysis was then performed to assess significant
predictors of clinical prolapse. All calculations were performed
using Stata 8.0, College Station, TX. The Partner’s Healthcare
Organization Institutional Review Board approved this study and the
Declaration of Helsinki protocols were followed.
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